Walleye Trading LLC Corcept Therapeutics Inc Transaction History

Walleye Trading LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$19.95 - $29.96 $36,867 - $55,366	1,848 New	1,848 $37,000
Q2 2021 Aug 16, 2021	SELL	$19.97 - $24.43 $278,062 - $340,163	-13,924 Reduced 84.66%	2,523 $56,000
Q3 2020 Nov 16, 2020	BUY	$12.46 - $19.98 $204,929 - $328,611	16,447 New	16,447 $286,000
Q1 2020 May 15, 2020	SELL	$10.11 - $14.04 $102,353 - $142,140	-10,124 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$12.06 - $16.96 $78,763 - $110,765	6,531 Added 181.77%	10,124 $123,000
Q3 2019 Nov 14, 2019	BUY	$10.41 - $14.66 $37,403 - $52,673	3,593 New	3,593 $51,000
Q4 2017 Feb 14, 2018	SELL	$15.77 - $20.72 $496,518 - $652,369	-31,485 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$12.3 - $19.3 $387,265 - $607,660	31,485	31,485 $608,000

346

86.1M

1.12M

667K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $5.35B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.